Education
About Us
Working with TipRanks
Follow Us
Carlsmed, Inc. (CARL)
NASDAQ:CARL
CARL Stock Chart & Stats
$13.26
--
Market closed
$13.26
--
Day’s Range― - ―
52-Week Range$11.55 - $17.19
Previous CloseN/A
VolumeN/A
Average Volume (3M)65.48K
Market Cap
$352.62M
Enterprise Value$258.10M
Total Cash (Recent Filing)$115.37M
Total Debt (Recent Filing)$17.61M
Price to Earnings (P/E)―
Beta2.56
Next Earnings
Feb 19, 2026EPS Estimate
-0.41Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.40
Shares Outstanding26,592,909
10 Day Avg. Volume85,401
30 Day Avg. Volume65,477
Financial Highlights & Ratios
PEG Ratio0.15
Price to Book (P/B)-3.40
Price to Sales (P/S)8.84
P/FCF Ratio-9.36
Enterprise Value/Market Cap0.73
Enterprise Value/Revenue5.77
Enterprise Value/Gross Profit7.71
Enterprise Value/Ebitda-10.74
Forecast
1Y Price Target
$20.25Price Target Upside52.71% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering5
EPS Forecast (FY)-2.67
Revenue Forecast (FY)$46.61M
Bulls Say, Bears Say
Bulls Say
Market AdoptionSurgeon adoption likely source of upside as spine surgeons favor new tech and feedback has been positive.
Revenue GrowthCARL is confident in its full year revenue guide due to strong new surgeon adoption and scheduled procedure volume visibility.
Technological AdvancementsCarlsmed’s Aprevo Technology Platform is pioneering a new standard of care in spine fusion surgery with custom 3D printed interbody implants and an AI enabled surgical planning software.
Bears Say
Carlsmed, Inc. News
CARL FAQ
What was Carlsmed, Inc.’s price range in the past 12 months?
Carlsmed, Inc. lowest stock price was $11.55 and its highest was $17.19 in the past 12 months.
What is Carlsmed, Inc.’s market cap?
Carlsmed, Inc.’s market cap is $352.62M.
When is Carlsmed, Inc.’s upcoming earnings report date?
Carlsmed, Inc.’s upcoming earnings report date is Feb 19, 2026 which is in 73 days.
How were Carlsmed, Inc.’s earnings last quarter?
Carlsmed, Inc. released its earnings results on Nov 06, 2025. The company reported -$0.4 earnings per share for the quarter, beating the consensus estimate of -$0.482 by $0.082.
Is Carlsmed, Inc. overvalued?
According to Wall Street analysts Carlsmed, Inc.’s price is currently Undervalued.
Does Carlsmed, Inc. pay dividends?
Carlsmed, Inc. does not currently pay dividends.
What is Carlsmed, Inc.’s EPS estimate?
Carlsmed, Inc.’s EPS estimate is -0.41.
How many shares outstanding does Carlsmed, Inc. have?
Carlsmed, Inc. has 26,592,909 shares outstanding.
What happened to Carlsmed, Inc.’s price movement after its last earnings report?
Carlsmed, Inc. reported an EPS of -$0.4 in its last earnings report, beating expectations of -$0.482. Following the earnings report the stock price went up 14.886%.
Which hedge fund is a major shareholder of Carlsmed, Inc.?
Currently, no hedge funds are holding shares in CARL
Carlsmed, Inc. Stock Smart Score
Company Description
Carlsmed, Inc.
Carlsmed, Inc. develops and operates a surgical platform for the treatment of complex adult spinal deformities that enables surgeons to harness clinical intelligence, advanced image recognition, and 3D printing technologies. Its product includes aprevo, a medical platform that makes surgical plans and devices tailored to the precise medical situation of every individual patient. It provides New Technology Add-On Payment (NTAP) reimbursement. The company was incorporated in 2018 and is based in Carlsbad, California.
CARL Earnings Call
Q3 2025
0:00 / 0:00
CARL Stock 12 Month Forecast
Average Price Target
$20.25
▲(52.71% Upside)
Technical Analysis
Ownership Overview
53.76% Insiders
4.40% Mutual Funds
7.14% Other Institutional Investors
32.72% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---